UNH Company Profile and Key Details
NYSE : UNH
UnitedHealth Group
$425.36
-1.17999-0.28%
At Close 4:00 PM64.82
BESG ScoreESG Rating
Price Chart
Stock Price Today
UnitedHealth Group Incorporated (UNH) stock declined over -0.28%, trading at $425.36 on NYSE, down from the previous close of $426.54. The stock opened at $428.13, fluctuating between $422.00 and $430.20 in the recent session.
Stock Snapshot
426.53999
Prev. Close
386.29B
Market Cap
422
Day Low
26.03
P/E Ratio
16.34
EPS (TTM)
11.42
Cash Flow per Share
428.13
Open
908.14M
Number of Shares
430.2
Day High
99.13%
Free Float in %
100.3
Book Value
3.85M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 02, 2026 | 428.13 | 430.20 | 420.54 | 425.36 | 3.85M |
| Jul 01, 2026 | 417.11 | 428.02 | 413.73 | 426.54 | 4.93M |
| Jun 30, 2026 | 422.72 | 422.74 | 413.25 | 415.63 | 5.54M |
| Jun 29, 2026 | 426.53 | 426.70 | 415.81 | 419.82 | 5.16M |
| Jun 26, 2026 | 416.16 | 427.93 | 416.16 | 427.89 | 10.22M |
| Jun 25, 2026 | 406.65 | 417.58 | 406.65 | 415.53 | 5.54M |
| Jun 24, 2026 | 410.54 | 413.43 | 400.00 | 405.80 | 6.8M |
| Jun 23, 2026 | 409.52 | 409.90 | 402.84 | 409.25 | 6.57M |
| Jun 22, 2026 | 402.14 | 409.46 | 402.14 | 406.68 | 5.77M |
| Jun 18, 2026 | 402.77 | 406.20 | 399.15 | 400.96 | 11.68M |
| Jun 17, 2026 | 409.12 | 411.16 | 398.59 | 399.53 | 5.76M |
| Jun 16, 2026 | 410.68 | 411.75 | 406.54 | 407.65 | 4.75M |
| Jun 15, 2026 | 406.70 | 414.16 | 399.65 | 411.04 | 6.63M |
| Jun 12, 2026 | 409.01 | 409.89 | 404.81 | 408.52 | 7.19M |
| Jun 11, 2026 | 408.71 | 409.98 | 403.11 | 405.55 | 4.89M |
| Jun 10, 2026 | 413.50 | 415.98 | 404.55 | 407.46 | 6.48M |
| Jun 09, 2026 | 409.99 | 413.00 | 407.44 | 413.00 | 7.64M |
| Jun 08, 2026 | 397.13 | 408.71 | 394.99 | 406.57 | 6.15M |
| Jun 05, 2026 | 399.54 | 404.04 | 397.20 | 399.47 | 10.59M |
| Jun 04, 2026 | 390.00 | 401.38 | 389.82 | 396.47 | 10.99M |
Contact Details
About Company
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
Company Information
| Employees | 400000 |
| Beta | 0.65 |
| Sales or Revenue | $400.28B |
| 5Y Sales Change% | 0.686% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Plans |
Stock Peers
ELV
1.7+0.41%
Elevance Health Inc.$417.89HUM-12.67-3.09%
Humana Inc.$396.75CI10.7+3.86%
Cigna Corporation$287.77MOH-2.68-1.15%
Molina Healthcare, Inc.$229.87CVS-0.09-0.09%
CVS Health Corp.$104.72CNC-0.49-0.72%
Centene Corp.$67.86OSCR0.28+0.88%
Oscar Health, Inc.$32.18BHG1.4+9.36%
Bright Health Group, Inc.$16.35Company Overview
UnitedHealth Group Incorporated (NYSE:UNH) closed at $425.36 USD, losing -$1.18 (-0.28%) from the previous close of $426.54. The stock is currently within 5% of its 52-week high $234.60 and $430.20. With a market capitalization of about $386.29 billion, UnitedHealth Group Incorporated is classified as a mega-cap and shows lower-than-market volatility (beta ~0.65). Key stats such as the average daily volume over the past year has been around 7.61 million shares, volume is running light vs its 52-week average. Headquartered in Eden Prairie, MN, UnitedHealth Group Incorporated operates in the Healthcare sector and the Medical - Healthcare Plans industry. Led by CEO Stephen J. Hemsley, the company employs approximately 400,000 people and listed since October 17, 1984. UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.
Technical Performance
UNH has shown mixed momentum, losing -0.61% over the past week and -5.1% over the past quarter, though year-to-date performance is up 2.52%. Short-term trend indicators are bullishly aligned (SMA20 1.3%, SMA50 -8.63%, SMA200 -9.24%). The stock’s 14-day RSI is 44.8 (neutral), while the ATR of 9.56 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -52.72% below its high and over 22.19% above its low. Average 10-day trading volume of 5.87 million shares is below the 3-month average of 7.49 million, indicating normal recent market interest.
Valuation Metrics
UnitedHealth Group Incorporated trades at a P/E ratio of 32.08, slightly below the S&P 500 average, with a price-to-sales ratio of 0.86 and a price-to-book ratio of 3.73 trading at moderately above to book value. The P/FCF stands at 19.64, also above market averages.
Dividend & Fair Value
UnitedHealth Group Incorporated last paid a dividend of 8.95 per share, this equals a trailing yield of roughly 1.31%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $305.16. This means the shares are trading above this model’s fair value.
Earnings & Analyst Outlook
UnitedHealth Group Incorporated generated EPS of $13.19 over the past year. Five-year average earnings growth is -3.76%. Wall Street analysts project EPS growth of 13.33% annually over the next five years. The latest quarter delivered EPS of $7.23. The next quarter is forecast at $6.78. Next year's EPS is expected at $11.83. Analyst sentiment is bullish. Analyst rating data shows there are 47 Strong Buy ratings, 15 Buy ratings, 6 Hold ratings, 0 Sell rating and 2 Strong Sell ratings. Price targets range from $492.00 to $198.00. The high target offers 15.67% upside. The low target suggests -53.45% downside. The mean target is $383.49. This offers -9.84% upside. UnitedHealth Group Incorporated earnings surprise history is a mixed track record. The quarter that ended April 21, 2026, missed forecasts by 9.88%. The prior quarter beat by 0.48%. Over the last six quarters, Apple has recorded several small beats. These include 1.04% in January 16, 2025.
Shareholding & Insider Activity
UnitedHealth Group Incorporated has 905.67 million shares outstanding. The public float is 897.82 million shares, elevated short interest at 1.32% of float. This equals 11.91 million shares. The short ratio is 0.56 days. Institutional investors hold 86.13% of the float. Insiders own 0.24%. BURKE RICHARD T holds 1.22 million shares, HEMSLEY STEPHEN J has 679.49 thousand shares and REX JOHN F has 203.80 thousand shares. Over the past six months, insider transactions show net selling. They sold 800.00 shares across 1 transactions.
Financial & Profitability Overview
On valuation metrics, UnitedHealth Group trades at a P/E of 32.08, P/S of 0.86 and P/B of 3.73. Liquidity is tight, with a current ratio of 0.80 and quick ratio of 0.80. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -36.72 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.75, supported by a cash flow-to-debt ratio of 0.30.
Quarterly Financial Highlights
The company ended the quarter with $29.63B in cash and short-term investments, a total debt of $67.44B, and net debt of $42.01B. Total assets were $278.42B, with equity of $98.92B. Financials further reflected stability, with operating cash flow of $29.07B, free cash flow of $25.68B, and capital expenditures of - $3.39B.
Price Forecast & Outlook
Our AI price prediction model suggests that UnitedHealth Group Incorporated stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.84%, with price expected at $437.44 by July 16, 2026, within a range of $428.43 to $446.84 3-Month Outlook: Projected rise of 198.57%, reaching $1.27 thousand by September 30, 2026, with a range of $1.24 thousand to $1.33 thousand. 1-Year Outlook: Projected loss of -25.74%, with price at $315.88 by July 02, 2027, within a range of $281.84 to $341.95.
Key Takeaways
UnitedHealth Group Incorporated (NYSE:UNH) shares are flat 2.52% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows UnitedHealth Group Incorporated trading at a premium to the broader market with a P/E of 32.08. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $480.66, suggesting 13.0% upside. Our AI forecast model points to short-term strength (2.84% over two weeks), a medium-term rise (198.57% over three months), and a longer-term loss (-25.74% over one year), with expected trading ranges indicating moderate volatility.
Frequently Asked Questions
What is the current UnitedHealth Group Incorporated (UNH) stock price?
UnitedHealth Group Incorporated (NYSE: UNH) stock price is $425.36 in the last trading session. During the trading session, UNH stock reached the peak price of $430.20 while $422.00 was the lowest point it dropped to. The percentage change in UNH stock occurred in the recent session was -0.28% while the dollar amount for the price change in UNH stock was - $1.18.
UNH's industry and sector of operation?
The NYSE listed UNH is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector. UnitedHealth Group Incorporated designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of UNH?
Mr. James T. Barry Jr.
Director of Sales for Western Pennsylvania
Sir Andrew Philip Witty
Chief Executive Officer & Non-Independent Director
Mr. Zachary William Sopcak
Senior Vice President of Capital Markets Communications & Investor Relations
Mr. Thomas Edward Roos
Senior Vice President & Chief Accounting Officer
Ms. Jennifer Mound Smoter
Senior Vice President & Chief Communications Officer
Mr. Sandeep Dadlani
Executive Vice President and Chief Digital & Technology Officer
Mr. John F. Rex
Executive Vice President & Chief Financial Officer
Mr. Terry M. Clark
Executive Vice President & Chief Marketing Officer
Mr. Rupert Bondy
Executive Vice President, Chief Legal Officer & Corporation Sec.
Mr. Dirk C. McMahon
Pres & Chief Operating Officer
Mr. Brian Robert Thompson
Executive Vice President & Chief Executive Officer of UnitedHealthcare
Director of Sales for Western Pennsylvania
Sir Andrew Philip Witty
Chief Executive Officer & Non-Independent Director
Mr. Zachary William Sopcak
Senior Vice President of Capital Markets Communications & Investor Relations
Mr. Thomas Edward Roos
Senior Vice President & Chief Accounting Officer
Ms. Jennifer Mound Smoter
Senior Vice President & Chief Communications Officer
Mr. Sandeep Dadlani
Executive Vice President and Chief Digital & Technology Officer
Mr. John F. Rex
Executive Vice President & Chief Financial Officer
Mr. Terry M. Clark
Executive Vice President & Chief Marketing Officer
Mr. Rupert Bondy
Executive Vice President, Chief Legal Officer & Corporation Sec.
Mr. Dirk C. McMahon
Pres & Chief Operating Officer
Mr. Brian Robert Thompson
Executive Vice President & Chief Executive Officer of UnitedHealthcare
How UNH did perform over past 52-week?
UNH's closing price is 81.31% higher than its 52-week low of $234.60 where as its distance from 52-week high of $430.20 is -1.12%.
How many employees does UNH have?
Number of UNH employees currently stands at 400,000.
Link for UNH official website?
Official Website of UNH is: https://www.unitedhealthgroup.com
How do I contact UNH?
UNH could be contacted at phone 800 328 5979 and can also be accessed through its website. UNH operates from 1 Health Drive, Eden Prairie, MN 55344, United States.
How many shares of UNH are traded daily?
UNH stock volume for the day was 3.85M shares. The average number of UNH shares traded daily for last 3 months was 7.61M.
What is the market cap of UNH currently?
The market value of UNH currently stands at $386.29B with its latest stock price at $425.36 and 908.14M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep